Researchers assess SARS-CoV-2 transmission risk during air travel

NewsGuard 100/100 Score

A team of scientists from the United States recently conducted a meta-analysis to estimate the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during air travel. The findings reveal that even with SARS-CoV-2-infected persons onboard, the risk of viral transmission is low inside an aircraft. The study is currently available on the medRxiv* preprint server.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

As of April 15, 2021, globally, there have been 136 million confirmed cases of coronavirus disease 2019 (COVID-19), including 2.9 million deaths, registered to the World Health Organization (WHO). At the initial phase of the pandemic, strict control measures applied to control the viral transmission have severely impacted the socioeconomic status of many countries globally. Because of national and international travel restrictions, the aviation industries have faced an almost 95% drop in passenger numbers during the initial phase of the pandemic.

As the pandemic progresses, the aviation-related services of many countries have been resumed to boost the global economy. This gives rise to global concerns about the risk of SARS-CoV-2 transmission among passengers traveling by air across the globe.

Viral transmission due to air travel can occur in two ways. A passenger with SARS-CoV-2 infection traveling via aircraft to a new location can transmit COVID-19 either on the ground or inside the aircraft.

In the current study, the scientists estimated the risk of SARS-CoV-2 transmission from an infected person to fellow passengers inside an aircraft.

Study design

The scientists conducted a systemic review of the present literature to estimate the number of index patients and secondary COVID-19 cases related to air travel between January 2020 and September 2020. An index patient refers to a passenger who was infected before air travel. A secondary COVID-19 case refers to the passenger who became infected from the index patient during air travel.

Because the primary focus of most of the published studies was infected passengers, the current risk estimation was limited to flights with index patients and did not involve the transmission risks among aircrew, ground crews, and airport staff.

The scientists estimated the risk of viral transmission using a quantitative approach that considered secondary cases and the total number of passengers inside an aircraft. The data collected from published literature were corrected for known data limitations, such as asymptomatic and underreported COVID-19 cases. Moreover, because COVID-19 testing and reporting processes vary across different locations/countries, uncertainties were also included in the risk calculation to obtain the most accurate risk estimation.

Important observations

According to the study findings, about 1.4 billion passengers traveled by air between January 2020 and September 2020. Among all air travelers, 2,866 were identified as index patients, and 44 were identified as potential secondary COVID-19 cases.

For estimating the risk of transmission during air travel, the scientists hypothesized that all possible transmissions occurred inside the aircraft cabin; however, they mentioned that in some cases, the transmission could have occurred elsewhere, such as in the airport.

Available literature on in-flight transmission

In a London-Hanoi flight on March 2, 2020, 15 secondary COVID-19 cases were identified. However, based on the duration between flight arrival and a positive SARS-CoV-2 test result, the scientists hypothesized that all these passengers were infected after the completion of air travel.

Furthermore, in a Singapore to Hangzhou, China flight on January 24, 2020, 15 index patients and only a single secondary COVID-19 case were identified. With further analysis, the scientists observed that except for eating food and drinking water, all 16 passengers wore masks throughout the air travel. However, the secondary case did not wear a mask properly when sitting in an unassigned seat surrounded by infected symptomatic passengers.

Estimated risk of in-flight transmission

By including all data correction factors in the calculations, the scientists estimated that the risk of SARS-CoV-2 transmission inside an aircraft cabin is 1 in 1.7 million. Furthermore, using the uncertainty estimates of publicly available literature, they estimated that the risk of in-flight transmission ranges from 1 case in every 712,000 passengers to 1 case in every 8 million passengers.

Study significance

The study reveals that the risk of SARS-CoV-2 transmission inside an aircraft cabin is as low as 1 case in 1.7 million passengers. In other words, the study findings indicate that even with index patients onboard, the overall risk of acquiring secondary infection is low during air travel.

Improved environmental control measures inside an aircraft cabin, such as high airflow, high-quality air purification, and seating arrangements, are believed to play a significant role in reducing the risk of viral transmission among passengers.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 18 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2023, May 18). Researchers assess SARS-CoV-2 transmission risk during air travel. News-Medical. Retrieved on May 23, 2024 from https://www.news-medical.net/news/20210415/SARS-CoV-2-transmission-risk-during-air-travel-could-be-low-says-study.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Researchers assess SARS-CoV-2 transmission risk during air travel". News-Medical. 23 May 2024. <https://www.news-medical.net/news/20210415/SARS-CoV-2-transmission-risk-during-air-travel-could-be-low-says-study.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Researchers assess SARS-CoV-2 transmission risk during air travel". News-Medical. https://www.news-medical.net/news/20210415/SARS-CoV-2-transmission-risk-during-air-travel-could-be-low-says-study.aspx. (accessed May 23, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2023. Researchers assess SARS-CoV-2 transmission risk during air travel. News-Medical, viewed 23 May 2024, https://www.news-medical.net/news/20210415/SARS-CoV-2-transmission-risk-during-air-travel-could-be-low-says-study.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 linked to rise in autoimmune lung disease, study finds